Elective percutaneous intervention for intracranial atherosclerotic stenoses by interventional cardiologists

Catheterization and Cardiovascular Interventions

Volumn 80, Issue 1, 2012, Pages 121-127

  Badawi, Ramy A ^a   White, Christopher J ^a   Collins, Tyrone J ^a   Jenkins, J Stephen ^a   Reilly, John P ^a   Grise, Mark A ^a   McMullan, Paul W ^a   Ramee, Stephen R ^a  

^a JOHN OCHSNER HEART AND VASCULAR INSTITUTE   (United States)

Author keywords

angioplasty; intracranial; intracranial stenosis; stenting; stroke; transient ischemia attack

Indexed keywords

ADULT; AGED; ARTERY CATHETERIZATION; ARTICLE; BRAIN ATHEROSCLEROSIS; BRAIN HEMORRHAGE; CARDIOLOGIST; CATHETER BASED THERAPY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; ELECTIVE SURGERY; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEART DEATH; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONSURGICAL INVASIVE THERAPY; OCCLUSIVE CEREBROVASCULAR DISEASE; PATIENT SAFETY; RESTENOSIS; TREATMENT OUTCOME; VERTEBRAL ARTERY STENOSIS;

AGED; ANGIOPLASTY, BALLOON; CEREBRAL ANGIOGRAPHY; DISEASE-FREE SURVIVAL; FEMALE; HOSPITAL MORTALITY; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; INTRACRANIAL ARTERIOSCLEROSIS; ISCHEMIC ATTACK, TRANSIENT; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEW ORLEANS; RECURRENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STENTS; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84862840670     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.23439     Document Type: Article

References (39)

1. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, et al. Heart disease and stroke statistics-2010 update: A report from the American Heart Association. Circulation 121: e46-e215.
2. Sacco RL, Kargman DE, Gu Q, Zamanillo MC,. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction: The Northern Manhattan stroke study. Stroke 1995; 26: 14-20.
3. Wong KS, Huang YN, Gao S, Lam WW, Chan YL, Kay R,. Intracranial stenosis in Chinese patients with acute stroke. Neurology 1998; 50: 812-813.
4. Gorelick PB,. Cerebrovascular disease in African Americans. Stroke 1998; 29: 2656-2664. (Pubitemid 28544021)
5. Chimowitz MI,. Angioplasty or stenting is not appropriate as first-line treatment of intracranial stenosis. Arch Neurol 2001; 58: 1690-1692. (Pubitemid 32963238)
6. Chimowitz ML, Lynn M, Howlett-Smith H, Stern B, Hertzberg V, Frankel M, Levine S, Chaturvedi S, Kasner S, Benesch C, Sila C, Jovin T, Romano J,. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005; 352: 1305-1316.
7. Thijs VN, Albers GW,. Symptomatic intracranial atherosclerosis: Outcome of patients who fail antithrombotic therapy. Neurology 2000; 55: 490-497. (Pubitemid 30647243)
8. Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack. A guidelie for healthcare professionals from the American Heart Association/American Stroke Association. Stroke.
9. Jiang WJ, Wang YJ, Du B, Wang SX, Wang GH, Jin M, Dai JP,. Stenting of symptomatic M1 stenosis of middle cerebral artery: An initial experience of 40 patients. Stroke 2004; 35: 1375-1380. (Pubitemid 38697461)
10. Kim JK, Ahn JY, Lee BH, Chung YS, Chung SS, Kim OJ, Kim WC, Joo JY,. Elective stenting for symptomatic middle cerebral artery stenosis presenting as transient ischaemic deficits or stroke attacks: Short term arteriographical and clinical outcome. J Neurol Neurosurg Psychiatry 2004; 75: 847-851. (Pubitemid 38658506)
11. Ramee SR, Dawson R, McKinley KL, Felberg R, Collins TJ, Jenkins JS, Awaad MI, White CJ,. Provisional stenting for symptomatic intracranial stenosis using a multidisciplinary approach: Acute results, unexpected benefit, and one-year outcome. Catheter Cardiovasc Interv 2001; 52: 457-467. (Pubitemid 32275034)
12. Rosenfield K, Babb JD, Cates CU, Cowley MJ, Feldman T, et al. Clinical competence statement on carotid stenting: Training and credentialing for carotid stenting-Multispecialty consensus recommendations: A report of the SCAI/SVMB/SVS writing committee to develop a clinical competence statement on carotid interventions. J Am Coll Cardiol 2005; 45: 165-174. (Pubitemid 40052047)
13. Social Security Death Index. Volume, 2008.
14. Kasner SE, Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, et al. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006; 113: 555-563.
15. Morgenstern LB, Fox AJ, Sharpe BL, Eliasziw M, Barnett HJ, Grotta JC,. The risks and benefits of carotid endarterectomy in patients with near occlusion of the carotid artery. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group. Neurology 1997; 48: 911-915.
16. Mazighi M, Tanasescu R, Ducrocq X, Vicaut E, Bracard S, Houdart E, Woimant F,. Prospective study of symptomatic atherothrombotic intracranial stenoses: The GESICA study. Neurology 2006; 66: 1187-1191. (Pubitemid 43739702)
17. Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. The EC/IC bypass study group. N Engl J Med 1985; 313: 1191-1200.
18. Mazighi M, Yadav JS, Abou-Chebl A,. Durability of endovascular therapy for symptomatic intracranial atherosclerosis. Stroke 2008; 39: 1766-1769.
19. Investigators SS,. Stenting of symptomatic atherosclerotic lesions in the vertebral or intracranial arteries (SSYLVIA): Study results. Stroke 2004; 35: 1388-1392.
20. Fiorella D, Levy EI, Turk AS, Albuquerque FC, Niemann DB, et al. US multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease: Periprocedural results. Stroke 2007; 38: 881-887. (Pubitemid 46568447)
21. Kurre W, Berkefeld J, Brassel F, Bruning R, Eckert B, et al. In-hospital complication rates after stent treatment of 388 symptomatic intracranial stenoses: Results from the INTRASTENT multicentric registry. Stroke 2010; 41: 494-498.
22. Siddiq F, Vazquez G, Memon MZ, Suri MF, Taylor RA, Wojak JC, Chaloupka JC, Qureshi AI,. Comparison of primary angioplasty with stent placement for treating symptomatic intracranial atherosclerotic diseases: A multicenter study. Stroke 2008; 39: 2505-2510.
23. Groschel K, Schnaudigel S, Pilgram SM, Wasser K, Kastrup A,. A systematic review on outcome after stenting for intracranial atherosclerosis. Stroke 2009; 40: e340-e347.
24. Ecker RD, Levy EI, Sauvageau E, Hanel RA, Hopkins LN,. Current concepts in the management of intracranial atherosclerotic disease. Neurosurgery 2006; 59 (Suppl 3): S210-S218; discussion S3-S13.
25. Levy EI, Hanel RA, Bendok BR, Boulos AS, Hartney ML, Guterman LR, Qureshi AI, Hopkins LN,. Staged stent-assisted angioplasty for symptomatic intracranial vertebrobasilar artery stenosis. J Neurosurg 2002; 97: 1294-1301. (Pubitemid 35424283)
26. Fiorella DJ, Turk AS, Levy EI, Pride GL Jr, Woo HH, et al. US Wingspan registry: 12-Month follow-up results. Stroke 2011; 42: 1976-1981.
27. Jiang WJ, Yu W, Du B, Gao F, Cui LY,. Outcome of patients with ≥70% symptomatic intracranial stenosis after wingspan stenting. Stroke 2011; 42: 1971-1975.
28. Abou-Chebl A,. Intracranial stenting with wingspan: Still awaiting a safe landing. Stroke 2011; 42: 1809-1811.
29. Kasner SE, Lynn MJ, Chimowitz MI, Frankel MR, Howlett-Smith H, et al. Warfarin vs aspirin for symptomatic intracranial stenosis: Subgroup analyses from WASID. Neurology 2006; 67: 1275-1278. (Pubitemid 44563843)
30. Connors JJ III, Wojak JC,. Percutaneous transluminal angioplasty for intracranial atherosclerotic lesions: Evolution of technique and short-term results. J Neurosurg 1999; 91: 415-423. (Pubitemid 29404433)
31. Gupta R, Schumacher HC, Mangla S, Meyers PM, Duong H, Khandji AG, Marshall RS, Mohr JP, Pile-Spellman J,. Urgent endovascular revascularization for symptomatic intracranial atherosclerotic stenosis [see comment]. Neurology 2003; 61: 1729-1735. (Pubitemid 38020820)
32. Yoon W, Seo JJ, Cho KH, Kim MK, Kim BC, Park MS, Kim TS, Kim JK, Kang HK,. Symptomatic middle cerebral artery stenosis treated with intracranial angioplasty: Experience in 32 patients. Radiology 2005; 237: 620-626. (Pubitemid 41507903)
33. Marks MP, Marcellus ML, Do HM, Schraedley-Desmond PK, Steinberg GK, Tong DC, Albers GW,. Intracranial angioplasty without stenting for symptomatic atherosclerotic stenosis: Long-term follow-up. Am J Neuroradiol 2005; 26: 525-530. (Pubitemid 43085952)
34. Marks MP, Wojak JC, Al-Ali F, Jayaraman M, Marcellus ML, Connors JJ, Do HM,. Angioplasty for symptomatic intracranial stenosis: Clinical outcome. Stroke 2006; 37: 1016-1020.
35. Abou-Chebl A, Bashir Q, Yadav JS,. Drug-eluting stents for the treatment of intracranial atherosclerosis: Initial experience and midterm angiographic follow-up. Stroke 2005; 36: e165-e168.
36. Gupta R, Al-Ali F, Thomas AJ, Horowitz MB, Barrow T, Vora NA, Uchino K, Hammer MD, Wechsler LR, Jovin TG,. Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation. Stroke 2006; 37: 2562-2566. (Pubitemid 44454680)
37. Qureshi AI, Kirmani JF, Hussein HM, Harris-Lane P, Divani AA, Suri MF, Janjua N, Alkawi A,. Early and intermediate-term outcomes with drug-eluting stents in high-risk patients with symptomatic intracranial stenosis. Neurosurgery 2006; 59: 1044-1051; discussion 1051. (Pubitemid 44852090)
38. Fiorella DJ, Levy EI, Turk AS, Albuquerque FC, Pride GL Jr, et al. Target lesion revascularization after wingspan: Assessment of safety and durability. Stroke 2009; 40: 106-110.
39. Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 2011; 365: 993-1003.